The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Interventions for valvular disease and heart failure
Real-world multicentre experience with the Direct Flow Medical® repositionable and retrievable transcatheter aortic valve implantation system for the treatment of high-risk patients with severe aortic stenosis
EuroIntervention 2016;11:e1314-e1320 published online e-edition February 2016. DOI: 10.4244/EIJV11I11A254
Christoph K. Naber1*, MD; Stylianos A. Pyxaras1, MD; Hüseyin Ince2, MD; Azeem Latib3, MD; Peter Frambach4, MD; Peter den Heijer5, MD; Daniel Wagner4, MD; Christian Butter6, MD; Antonio Colombo3, MD; Stephan Kische2, MD
1. Contilia Heart and Vascular Centre, Elisabeth-Krankenhaus Essen, Essen, Germany; 2. Innere Medizin – Kardiologie und konservative Intensivmedizin, Vivantes Klinikum im Friedrichshain, Berlin, Germany; 3. Interventional Cardiology Unit, San Raffaele Sci
Aims: Our aim was to assess the performance of the Direct Flow Medical (DFM) repositionable and retrievable transcatheter aortic valve implantation (TAVI) system in high-risk patients wit
Sign in to read and download the full article
Forgot your password? No account yet?
Sign up for free!
Create my pcr account Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
repositionabilityretrievabilitysevere aortic stenosistranscatheter aortic valve implantation
Interventions for valvular diseaseTAVITools, devices and techniques
Read next article
Edwards SAPIEN 3 implanted in a failing aortic bioprosthesis: first report